Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001062993-14-006103
Filing Date
2014-10-23
Accepted
2014-10-23 16:32:29
Documents
4
Period of Report
2014-10-23
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A form8k.htm 8-K/A 8533
2 EXHIBIT 16.1 exhibit16-1.htm EX-16.1 1183
3 GRAPHIC exhibi1.jpg GRAPHIC 10849
4 GRAPHIC exhibi2.jpg GRAPHIC 10125
  Complete submission text file 0001062993-14-006103.txt   39976
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34236 | Film No.: 141170308
SIC: 2834 Pharmaceutical Preparations